STRATOSVIR LIMITED

13099988
Active Ingatestone

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

STRATOSVIR LIMITED

13099988

Research and experimental development on biotechnology

Founded 24 Dec 2020 Active Ingatestone, England 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 31 Dec 2026 6 months remaining
Confirmation
Net assets £147K £41K 2024 year on year
Total assets £155K £23K 2024 year on year
Total Liabilities £8K £18K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

46-54 High Street Ingatestone CM4 9DW England

Website

www.example.com

Full company profile for STRATOSVIR LIMITED (13099988), an active life sciences and medical technology company based in Ingatestone, England. Incorporated 24 Dec 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£53.76k

Decreased by £67.08k (-56%)

Net Assets

£146.95k

Increased by £40.84k (+38%)

Total Liabilities

£7.58k

Decreased by £17.88k (-70%)

Turnover

N/A

Employees

5

Increased by 3 (+150%)

Debt Ratio

5%

Decreased by 14 (-74%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 51,254 Shares £604k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Feb 20262,450£63k£25.645
6 Jun 20243,449£50k£14.498
6 Jun 20245,949£86k£14.498
27 Mar 20248,278£120k£14.498
27 Mar 2024344£5k£14.498

Officers

Officers

3 active
Status
Christopher Graeme UllmanDirectorBritishEngland5724 Dec 2020Active
Juan Antonio PostigoDirectorDutchUnited Kingdom5510 May 2021Active
Priya MandeDirectorBritishUnited Kingdom556 Nov 2023Active

Shareholders

Shareholders (11)

Christopher Graeme Ullman
30.0%
40,000
Juan Antonio Postigo
30.0%
40,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Juan Antonio Postigo

Dutch

Active
Notified 14 Apr 2021
Residence United Kingdom
DOB December 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Christopher Graeme Ullman

British

Active
Notified 24 Dec 2020
Residence England
DOB November 1968
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Jun 2026CapitalAllotment of shares (GBP 135.862) on 27 Feb 2026
25 Mar 2026MiscellaneousReplacement filing of SH01 - 14/04/21 Statement of Capital gbp 133.412
25 Mar 2026MiscellaneousReplacement filing of SH01 - 23/04/21 Statement of Capital gbp 133.412
21 Mar 2026ResolutionResolutions
21 Mar 2026ResolutionResolutions
17 Jun 2026 Capital

Allotment of shares (GBP 135.862) on 27 Feb 2026

25 Mar 2026 Miscellaneous

Replacement filing of SH01 - 14/04/21 Statement of Capital gbp 133.412

25 Mar 2026 Miscellaneous

Replacement filing of SH01 - 23/04/21 Statement of Capital gbp 133.412

21 Mar 2026 Resolution

Resolutions

21 Mar 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Allotment of shares (GBP 135.862) on 27 Feb 2026

2 weeks ago on 17 Jun 2026

Replacement filing of SH01 - 14/04/21 Statement of Capital gbp 133.412

3 months ago on 25 Mar 2026

Replacement filing of SH01 - 23/04/21 Statement of Capital gbp 133.412

3 months ago on 25 Mar 2026

Resolutions

3 months ago on 21 Mar 2026

Resolutions

3 months ago on 21 Mar 2026